Cancer’s ability to elude the immune system is a well-known characteristic. While much research has focused on somatic mutations within cancer cells that enable this evasion, little attention has been given to somatic mutations in tumor-infiltrating immune (TII) cells. These mutations do not directly fuel tumor growth but may indirectly support it by hindering an effective anti-tumor immune response. In essence, investigating these mutations in TII cells could provide valuable insights into how cancers manage to evade our immune defenses.
Related Posts
Is AI better at assessing heart health than sonographers?
Artificial intelligence (AI) is now better at assessing heart health than sonographers, according to a new study published in Nature. The study found that AI was able to more accurately diagnose cardiac function than sonographers, and that cardiologist required less time and made fewer changes to AI-generated assessments. This is a major breakthrough in the […]
Nature’s remedy: Ethanolic extract of Murraya koenigii leaves tackles obesity and glucose level
The ethanolic extract of Murraya koenigii (L) leaves demonstrates anti-obesity and hypoglycemic effects in rats subjected to a high-fat diet. This research illuminates the potential therapeutic benefits of this plant extract in addressing obesity-related complications, offering insights into its dual impact on weight management and glucose regulation. The observed effects highlight the significance of natural […]
Enzyme-Linked Immunosorbent Assay (ELISA): Detecting the Invisible
Enzyme immunoassays (EIAs) use the catalytic properties of enzymes to detect and quantify immunologic reactions. Enzyme-linked immunosorbent assay (ELISA) is a heterogeneous EIA technique used in clinical analyses. In this type of assay, one of the reaction components is nonspecifically adsorbed or covalently bound to the surface of a solid phase, such as a microtiter […]